Quarterly Report

FENNEC PHARMACEUTICALS INC. Filed 2023-11-09 Acc 0001558370-23-018614

Documents 1

2024-05-14 10-Q Quarterly Report
2023-11-09 10-Q Quarterly Report
2023-11-09 4 CHIEF EXECUTIVE OFFICER sold 25,044 shares at an average $7.76 ($194,267)
2023-11-09 S-3 Registration Statement
2023-11-08 144 Sale of Securities
2023-11-07 8-K Results of operations
2023-08-07 10-Q Quarterly Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading fencf-20230930x10q.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…